| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 26, 2026
Positive data for FARAPULSE™ Pulsed Field Ablation and WATCHMAN™ LAAC Devices underscore therapy safety and effectiveness in late-breaking clinical trial sessions MARLBOROUGH, Mass. and...
-
Apr 15, 2026
GALWAY, Ireland, 15 April 2026 - Boston Scientific Corporation (NYSE: BSX) – a global leader in medical device technology – today announced a €75 million investment in its Galway site,...
-
Mar 28, 2026
Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial...
Mar 28, 2026Global randomized trial demonstrated statistically significant reduction in clinical event rates in patients with intermediate-risk PE when treated with the EKOS device plus anticoagulation vs....
-
Sep 18, 2025Conduction system pacing technique may promote greater ventricular synchrony and reduce long-term risk of heart failure associated with traditional right ventricular pacing
PARIS, France, 18 September 2025 – Boston Scientific Corporation (NYSE: BSX) has received CE mark approval to expand the indication for its current-generation INGEVITY™+ Pacing Leads – thin...